Iron Deposition in the Bone Marrow and Spleen of Nonhuman Primates with Acute Radiation Syndrome
Radiation Research · 16.11.2023 · 200 (6) · 593-600
DOI: 10.1667/rade-23-00107.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation Research, erschienen am 16.11.2023. Verfasst von Regina M Day und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services Universi…. Hauptthemen laut MEDLINE: Bone Marrow, Acute Radiation Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The risk of exposure to high levels of ionizing radiation from nuclear weapons or radiological accidents is an increasing world concern. Partial- or total-body exposure to high doses of radiation is potentially lethal through the induction of acute radiation syndrome (ARS). Hematopoietic cells are sensitive to radiation exposure; white blood cells primarily undergo apoptosis while red blood cells (RBCs) undergo hemolysis. Several laboratories demonstrated that the rapid hemolysis of RBCs results in the release of acellular iron into the blood. We recently demonstrated using a murine model of ARS after total-body irradiation (TBI) and the loss of RBCs, iron accumulated in the bone marrow and spleen, notably between 4–21 days postirradiation. Here, we investigated iron accumulation in the bone marrow and spleens from TBI nonhuman primates (NHPs) using histological stains. We observed trends in increased intracellular and extracellular brown pigmentation in the bone marrow after various doses of radiation, especially after 4–15 days postirradiation, but these differences did not reach significance. We observed a significant increase in Prussian blue-staining intracellular iron deposition in the spleen 13–15 days after 5.8–8.5 Gy of TBI. We observed trends of increased iron in the spleen after 30–60 days postirradiation, with varying doses of radiation, but these differences did not reach significance. The NHP model of ARS confirms our earlier findings in the murine model, showing iron deposition in the bone marrow and spleen after TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
- Pathology Department, Research Services, Naval Medical Research Center, Silver Spring, Maryland 20910.
- Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
- Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
Zitieren
APA
Day, R. M., Rittase, W. B., Slaven, J. E., Lee, S. H., Brehm, G. V., Bradfield, D. T., Muir, J. M., Wise, S. Y., Fatanmi, O. O., & Singh, V. K. (2023). Iron Deposition in the Bone Marrow and Spleen of Nonhuman Primates with Acute Radiation Syndrome. Radiation Research, 200(6), 593-600. https://doi.org/10.1667/rade-23-00107.1
Vancouver
Day RM, Rittase WB, Slaven JE, Lee SH, Brehm GV, Bradfield DT, et al. Iron Deposition in the Bone Marrow and Spleen of Nonhuman Primates with Acute Radiation Syndrome. Radiation Research. 2023;200(6):593-600. doi:10.1667/rade-23-00107.1
BibTeX
@article{Day2023,
author = {Day, Regina M and Rittase, W Bradley and Slaven, John E and Lee, Sang-Ho and Brehm, Grace V and Bradfield, Dmitry T and Muir, Jeannie M and Wise, Stephen Y and Fatanmi, Oluseyi O and Singh, Vijay K},
title = {Iron Deposition in the Bone Marrow and Spleen of Nonhuman Primates with Acute Radiation Syndrome},
journal = {Radiation Research},
year = {2023},
volume = {200},
number = {6},
pages = {593--600},
doi = {10.1667/rade-23-00107.1}
}
EUVIMED